![Michele Korfin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michele Korfin
Director/Board Member at
ORGANOGENESIS HOLDINGS INC.
Net worth: 488 930 $ as of 2026-05-30
Profile
Ms. Michele I.
Korfin is an Independent Director at Organogenesis Holdings, Inc. and a Chief Executive Officer at Australis Pharma.
She is on the Board of Directors at Organogenesis Holdings, Inc. Ms. Korfin was previously employed as a Chief Operating & Commercial Officer by Gamida Cell Ltd., a Chief Operating Officer by Tyme Technologies, Inc., a Vice President-Market Access by Kite Pharma, Inc., a Head-Oncology Sales Force by Celgene Corp., and a Secretary & Trustee by BioNJ, Inc. She received her undergraduate degree from Rutgers State University of New Jersey and an MBA from Harvard Business School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-09 | 190,245 ( 0.15% ) | 488 930 $ | 2026-05-30 |
Michele Korfin active positions
| Companies | Position | Start |
|---|---|---|
| ORGANOGENESIS HOLDINGS INC. | Director/Board Member | 2022-05-02 |
Former positions of Michele Korfin
| Companies | Position | End |
|---|---|---|
| GAMIDA CELL LTD. | Chief Operating Officer | 2024-03-31 |
| TYME TECHNOLOGIES, INC. | Chief Operating Officer | 2019-12-31 |
| KITE PHARMA INC | Corporate Officer/Principal | 2018-06-30 |
| CELGENE | Corporate Officer/Principal | 2016-02-29 |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services Promotes the biotechnology industry in New Jersey | Director/Board Member | - |
Training of Michele Korfin
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
63
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Tyme Technologies, Inc.
 Tyme Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops cancer metabolism-based therapeutics | Health Technology |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gamida Cell Ltd.
 Gamida Cell Ltd. Pharmaceuticals: MajorHealth Technology Engages in the development of cell therapies to cure blood cancer and rare serious hematologic diseases | Health Technology |
BioNJ, Inc.
BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services Promotes the biotechnology industry in New Jersey | Commercial Services |
Kite Pharma, Inc.
 Kite Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which engages in the development of novel cancer immunotherapeutic products | Health Technology |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Organogenesis Holdings, Inc.
 Organogenesis Holdings, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and commercializes regenerative medicines products for the advanced wound care and surgical and sports medicine markets | Health Technology |
- Stock Market
- Insiders
- Michele Korfin
